Challenges in implementing clinical liquid chromatography-tandem mass spectrometry methods - Seeing the light at the end of the tunnel

Journal of Mass Spectrometry

Volumn 48, Issue 7, 2013, Pages 755-767

  Clarke, William ^a   Rhea, Jeanne M ^b   Molinaro, Ross ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

challenges; clinical LC MS MS; guidance; implementation; regulations

Indexed keywords

ACCEPTABILITY CRITERION; CHALLENGES; IMPLEMENTATION; LC-MS/MS; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC MS/MS); LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; REGULATIONS; US FOOD AND DRUG ADMINISTRATION;

ASSAYS; ELECTRONIC GUIDANCE SYSTEMS; MASS SPECTROMETRY; RESEARCH;

LIQUID CHROMATOGRAPHY;

ACCURACY; ARTICLE; CLINICAL LABORATORY; FEASIBILITY STUDY; HUMAN; IMMUNOASSAY; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TURNAROUND TIME; VALIDITY;

CHALLENGES; CLINICAL LC-MS/MS; GUIDANCE; IMPLEMENTATION; REGULATIONS;

CHROMATOGRAPHY, LIQUID; CLINICAL LABORATORY TECHNIQUES; HUMANS; TANDEM MASS SPECTROMETRY;

EID: 84879906458     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.3214     Document Type: Article

References (58)

1. J. R. Yates, III,. A century of mass spectrometry: from atoms to proteomes. Nat. Methods 2011, 8, 633-637.
2. S. K. Grebe, R. J. Singh,. LC-MS/MS in the clinical laboratory-where to from here? Clin. Biochem. Rev. 2011, 32, 5-31.
3. T. Zima,. Quality in laboratory diagnostics: from theory to practice. Biochemia Medica. 2010, 20, 215-220.
4. B. N. Swanson,. Delivery of high-quality biomarker assays. Dis. Markers 2002, 18, 47-56. (Pubitemid 35191658)
5. A. Ferreira-Gonzalez, C. T. Garrett,. Laboratory developed tests in molecular diagnostics. In Molecular Diagnostics for the Clinical Laboratorian, W. B. Coleman, G. J. Tsongalis, (Eds). Humana Press, 2006, 247-257.
6. J. W. Lenders, K. Pacak, M. M. Walther, W. M. Linehan, M. Mannelli, P. Friberg, H. R. Keiser, D. S. Goldstein, G. Eisenhofer,. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002, 287, 1427-34. (Pubitemid 34250506)
7. J. W. Honour,. Development and validation of a quantitative assay based on tandem mass spectrometry. Ann. Clin. Biochem. 2011, 48, 97-111.
8. R. A. Bowen, G. L. Hortin, G. Csako, O. H. Otanez, A. T. Remaley,. Impact of blood collection devices on clinical chemistry assays. Clin. Biochem. 2010, 43, 4-25.
9. R. Z. Shi, H. H. van Rossum, R. A. Bowen,. Serum testosterone quantitation by liquid chromatography-tandem mass spectrometry: interference from blood collection tubes. Clin. Biochem. 2012, 45, 1706-9.
10. M. M. Kushnir, A. L. Rockwood, W. L. Roberts, B. Yue, J. Bergquist, A. W. Meikle,. Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin. Biochem. 2011, 44, 77-88.
11. M. Vogeser, F. Kirchhoff,. Progress in automation of LC-MS in laboratory medicine. Clin. Biochem. 2011, 44, 4-13.
12. M. Vogeser, C. Seger,. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin. Chem. 2010, 56, 1234-44.
13. E. Stokvis, H. Rosing, J. H. Beijnen,. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? Rapid Commun. Mass Spectrom. 2005, 19, 401-7. (Pubitemid 40203858)
14. J. M. Rhea, D. French, R. J. Molinaro,. Direct total and free testosterone measurement by liquid chromatography tandem mass spectrometry across two different platforms. Clin. Biochem. 2013. doi: 10.1016/j.clinbiochem. 2013.01.005.
15. F. G. Strathmann, A. N. Hoofnagle,. Current and future applications of mass spectrometry to the clinical laboratory. Am. J. Clin. Pathol. 2011, 136, 609-16.
16. M. M. Kushnir, A. L. Rockwood, G. J. Nelson, B. Yue, F. M. Urry,. Assessing analytical specificity in quantitative analysis using tandem mass spectrometry. Clin. Biochem. 2005, 38, 319-27. (Pubitemid 40342862)
17. S. Podnar,. Comparison of parametric and nonparametric reference data in motor unit potential analysis. Muscle Nerve 2008, 38, 1412-9.
18. D. B. Endres,. Reference intervals. In Contemporary Practice in Clinical Chemistry, W. Clarke, and, D. R. Dufour, (Eds). American Association for Clinical Chemistry, 2006.
19. EMEA CMPH. Guideline on validation of bioanaytical methods. Committee for Medicinal Products for Human Use, 2011. Available from: http://www.emea.europa. eu/docs/en-GB/document-library/Scientific-guideline/2009/12/WC500018062.pdf.
20. Guidance for Industry: Bioanalytical Method Validation, C.a.C. U.S. Department of Health and Human Services: FDA, Editor.
21. CLSI. Evaluation of precision performance of quantitative measurement methods; approved guideline. 2004.
22. H. Chen, L. F. McCoy, R. L. Schleicher, C. M. Pfeiffer,. Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. Clin. Chim. Acta 2008, 391, 6-12.
23. CLIA. Health care financing administration (42 CFR Part 493), the Public Health Service, US Department of Health and Human Services: Clinical Laboratory Improvement Amendments of 1988, 1988.
24. NCCLS/CLSI. Estimation of total analytical error for clinical laboratory methods; approved guideline. NCCLS/CLSI document EP21-A. 2003.
25. CLSI. Interference testing in clinical chemistry; approved guideline-second edition. CLSI document EP07-A2. 2005.
26. CLSI. Method comparison and bias estimation using patient samples; approved guideline-second edition (interim revision). CLSI document EP09-A2-IR. 2010.
27. H. C. Stepman, A. Vanderroost, K. Van Uytfanghe, L. M. Thienpont,. Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin. Chem. 2011, 57, 441-8.
28. J. C. Botelho, C. Shacklady, H. C. Cooper, S. S. Tai, K. Van Uytfanghe, L. M. Thienpont, H. W. Vesper,. Isotope-dilution liquid chromatography-tandem mass spectrometry candidate reference method for total testosterone in human serum. Clin. Chem. 2013, 59, 372-80.
29. J. O. Jeppsson, U. Kobold, J. Barr, A. Finke, W. Hoelzel, T. Hoshino, K. Miedema, A. Mosca, P. Mauri, R. Paroni, L. Thienpont, M. Umemoto, C. Weykamp, International Federation of Clinical C, Laboratory M. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin. Chem. Lab. Med. 2002, 40, 78-89. (Pubitemid 34196455)
30. W. J,. Basic QC Practices: Training in Statistical Quality Control for Medical Laboratories. Madison WI Westgard Quality Corporation, 2010.
31. P. J. Twomey, M. H. Kroll,. How to use linear regression and correlation in quantitative method comparison studies. Int. J. Clin. Pract. 2008, 62, 529-38. (Pubitemid 351348037)
32. BIPM. Database of higher-order reference materials, measurement methods/procedures and services. [cited 2012 December 17, 2012]. Available from: http://www.bipm.org/jctlm/home.do.
33. CLSI. User verification of performance for precision and trueness; approved guideline-second edition. CLSI document EP15-A2, 2005.
34. D. H. Chace,. Mass spectrometry in the clinical laboratory. Chem. Rev. 2001, 101, 445-77. (Pubitemid 32325801)
35. R. J. Singh, S. K. Grebe, B. Yue, A. L. Rockwood, J. C. Cramer, Z. Gombos, G. Eisenhofer,. Precisely wrong? Urinary fractionated metanephrines and peer-based laboratory proficiency testing. Clin. Chem. 2005, 51, 472-3; discussion 473-474.
36. C. Kousoulos, Y. Dotsikas, Y. L. Loukas,. Turbulent flow and ternary column-switching on-line clean-up system for high-throughput quantification of risperidone and its main metabolite in plasma by LC-MS/MS: application to a bioequivalence study. Talanta 2007, 72, 360-7. (Pubitemid 46566377)
37. J. G. Swales, R. T. Gallagher, M. Denn, R. M. Peter,. Simultaneous quantitation of metformin and sitagliptin from mouse and human dried blood spots using laser diode thermal desorption tandem mass spectrometry. J. Pharm. Biomed. Anal. 2011, 55, 544-51.
38. X. Wu, J. Wang, L. Tan, J. Bui, E. Gjerstad, K. McMillan, W. Zhang,. In vitro ADME profiling using high-throughput rapid fire mass spectrometry: cytochrome p450 inhibition and metabolic stability assays. J. Biomol. Screen. 2012, 17, 761-72.
39. P. J. Taylor, K. K. Forrest, P. Salm, P. I. Pillans,. Single-point calibration for sirolimus quantification. Ther. Drug Monit. 2001, 23, 726-7.
40. M. T. Olson, A. Breaud, R. Harlan, N. Emezienna, S. Schools, A. L. Yergey, W. Clarke,. Alternative calibration strategies for the clinical laboratory: application to nortriptyline therapeutic drug monitoring. Clin. Chem. 2013.
41. W. G. Miller, G. L. Myers, E. R. Ashwood, A. A. Killeen, E. Wang, L. M. Thienpont, L. Siekmann,. Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch. Pathol. Lab. Med. 2005, 129, 297-304. (Pubitemid 40343981)
42. S. Gutman,. The role of Food and Drug Administration regulation of in vitro diagnostic devices-applications to genetics testing. Clin. Chem. 1999, 45, 746-9. (Pubitemid 29220350)
43. K. L. Napoli, C. Hammett-Stabler, P. J. Taylor, W. Lowe, M. E. Franklin, M. R. Morris, D. P. Cooper,. Multi-center evaluation of a commercial Kit for tacrolimus determination by LC/MS/MS. Clin. Biochem. 2010, 43, 910-20.
44. S. Vogliardi, D. Favretto, M. Tucci, G. Stocchero, S. D. Ferrara,. Simultaneous LC-HRMS determination of 28 benzodiazepines and metabolites in hair. Anal. Bioanal. Chem. 2011, 400, 51-67.
45. I. Ojanpera, M. Kolmonen, A. Pelander,. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Anal. Bioanal. Chem. 2012, 403, 1203-20.
46. G. Lawson, E. Cocks, S. Tanna,. Quantitative determination of atenolol in dried blood spot samples by LC-HRMS: a potential method for assessing medication adherence. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2012, 897, 72-9.
47. H. Henry, H. R. Sobhi, O. Scheibner, M. Bromirski, S. B. Nimkar, B. Rochat,. Comparison between a high-resolution single-stage Orbitrap and a triple quadrupole mass spectrometer for quantitative analyses of drugs. Rapid Commun. Mass Spectrom. 2012, 26, 499-509.
48. N. L. Anderson, N. G. Anderson, L. R. Haines, D. B. Hardie, R. W. Olafson, T. W. Pearson,. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J. Proteome Res. 2004, 3, 235-44. (Pubitemid 38500990)
49. K. A. Tubbs, D. Nedelkov, R. W. Nelson,. Detection and quantification of beta-2-microglobulin using mass spectrometric immunoassay. Anal. Biochem. 2001, 289, 26-35. (Pubitemid 32121565)
50. N. J. Clarke, Y. Zhang, R. E. Reitz,. A novel mass spectrometry-based assay for the accurate measurement of thyroglobulin from patient samples containing antithyroglobulin autoantibodies. J. Investig. Med. 2012, 60, 1157-63.
51. M. M. Kushnir, A. L. Rockwood, W. L. Roberts, D. Abraham, A. N. Hoofnagle, A. W. Meikle,. Measurement of thyroglobulin by liquid chromatography/tandem mass spectrometry in serum and plasma in the presence of anti-thyroglobulin autoantibodies. Clin. Chem. 2013.
52. J. He, Y. Liu, T. S. Zhu, X. Xie, M. A. Costello, C. E. Talsma, C. G. Flack, J. G. Crowley, F. Dimeco, A. L. Vescovi, X. Fan, D. M. Lubman,. Glycoproteomic analysis of glioblastoma stem cell differentiation. J. Proteome Res. 2011, 10, 330-8.
53. C. Yuan, J. Kosewick, X. He, M. Kozak, S. Wang,. Sensitive measurement of serum 1alpha,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction. Rapid Commun. Mass Spectrom. 2011, 25, 1241-9.
54. J. Stahl-Zeng, V. Lange, R. Ossola, K. Eckhardt, W. Krek, R. Aebersold, B. Domon,. High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol. Cell. Proteomics 2007, 6, 1809-17. (Pubitemid 350031682)
55. R. Sturm, G. Sheynkman, C. Booth, L. M. Smith, J. A. Pedersen, L. Li,. Absolute quantification of prion protein (90-231) using stable isotope-labeled chymotryptic peptide standards in a LC-MRM AQUA workflow. J. Am. Soc. Mass Spectrom. 2012, 23, 1522-33.
56. J. O. Becker, A. N. Hoofnagle,. Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS. Bioanalysis 2012, 4, 281-90.
57. [ cited 2013 March 8 ]. Available from: http://www.swgtox.org/documents/ Validation-public-comment.pdf.
58. CLSI. Mass spectrometry in the clinical laboratory: general principles and guidance; approved guideline. CLSI document C50-A. 2007.